ArticleSystematic reviews2022

Immunotherapy for people with clinically isolated syndrome or relapsing-remitting multiple sclerosis: treatment response by demographic, clinical, and biomarker subgroups (PROMISE)-a systematic review protocol.

Thomas Lehnert et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.